Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(6):443–450. doi: 10.1002/clc.4960240605

Effect of coronary risk factors on arterial compensatory enlargement in japanese middle‐aged patients with de novo single‐vessel disease—An intravascular ultrasound study

Kikuo Isoda 1, Koh Arakawa 1,, Yashuhiro Kamezawa 1, Ken‐Ya Nishizawa 1, Ken‐Ichirou Nishikawa 1, Toshio Shibuya 1, Fumitaka Ohsuzu 1, Haruo Nakamura 1
PMCID: PMC6654925  PMID: 11403505

Abstract

Background: Compensatory enlargement (CE) of atherosclerotic human arteries has been reported; however, the pattern of arterial remodeling in response to plaque formation is not unique.

Hypothesis: The study was undertaken to determine the extent of coronary artery compensatory enlargement at stenotic lesions and to correlate the arterial compensatory enlargement with risk factors.

Methods: We studied 62 patients with stable angina and de novo single‐vessel disease using intravascular ultrasound and obtained good images in 42 patients (68%). The vessel cross‐sectional area (VA), lumen cross‐sectional area (LA), and plaque cross‐sectional area (PA) were measured at the lesion site and at proximal and distal reference sites. Positive CE was defined as increase in VA of lesion site > 10% compared with that of proximal reference site (CE group, n = 15); shrinkage was defined as reduction in VA of lesion site > 10% compared with that of proximal reference site (S group, n = 14); inadequate CE was defined as intermediate between CE and S (IE group, n = 13). All subjects had coronary risk factors measured before this study.

Results: There was no difference in VA, LA, or PA among the three groups at the proximal and distal reference sites, nor in LA at the lesion site; however, VA and PA were significantly smaller in the S group than in the other groups (p < 0.01). Of coronary risk factors, increased systolic blood pressure (SBP), increased diastolic blood pressure (DBP), and decreased high‐density lipoprotein cholesterol (HDL‐c) levels had the strongest association with shrinkage (p < 0.05).

Conclusion: Hypertension and decreased HDL level may contribute to the shrinkage response in middle‐aged patients with stable angina.

Keywords: atherosclerosis, compensatory enlargement, coronary risk factors

Full Text

The Full Text of this article is available as a PDF (803.3 KB).

References

  • 1. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis G: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371–1375 [DOI] [PubMed] [Google Scholar]
  • 2. Pasterkamp G, Wensing PJW, Post MJ, Hillen B, Mali WPTM, Borst C: Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 1995; 91: 1444–1449 [DOI] [PubMed] [Google Scholar]
  • 3. Pasterkamp G, Borst C, Post MJ, Mali WPTM, Wensing PJW, Gussenhoven EJ, Hillen B: Atherosclerotic arterial remodeling in the superficial femoral artery. Circulation 1996; 93: 1818–1825 [DOI] [PubMed] [Google Scholar]
  • 4. Mintz GS, Kent KM, Pichard AD, Satler LW, Popma JJ, Leon MB: Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses: An intravascular ultrasound study. Circulation 1997; 95: 1791–1798 [DOI] [PubMed] [Google Scholar]
  • 5. Hodgson JMcB, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan HM: Intracoronary ultrasound imaging: Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol 1993; 21: 35–44 [DOI] [PubMed] [Google Scholar]
  • 6. Armstrong ML, Heistad DD, Marcus ML, Megan MB, Piegors DJ: Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis 1985; 5: 336–346 [DOI] [PubMed] [Google Scholar]
  • 7. Bond MG, Adams MR, Bullock BC: Complicating factors in evaluating coronary artery atherosclerosis. Artery 1981; 9: 21–29 [PubMed] [Google Scholar]
  • 8. Hermiller JB, Tenaglia AN, Kisslo KB, Phillips HR, Bashore TM, Davidson CJ: In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993; 71: 665–668 [DOI] [PubMed] [Google Scholar]
  • 9. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM: Extent and direction of arterial remodeling in stable vs. unstable coronary syndromes. Circulation 2000; 101: 598–603 [DOI] [PubMed] [Google Scholar]
  • 10. Holvoet P, Theilmeier G, Shivalkar B, Flameng W, Collen D: LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998; 18: 415–422 [DOI] [PubMed] [Google Scholar]
  • 11. Ehara S, Ueda M, Naruko T, Itagane H, Haze K, Itabe H, Takano T, Tsukamoto Y, Komatsu R, Kojima A, Becker AE: Plasma levels of oxidized low density lipoprotein directly relate to the severity of the acute coronary syndromes. Circulation 1998; 96: 1–765 [DOI] [PubMed] [Google Scholar]
  • 12. Hamasaki S, Higano ST, Suwaida JA, Nishimura RA, Miyauchi K, Holmes DR, Lerman A: Cholesterol‐lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol 2000; 20: 737–743 [DOI] [PubMed] [Google Scholar]
  • 13. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27–36 [DOI] [PubMed] [Google Scholar]
  • 14. Taylor AJ, Burke AP, Farb A, Yousefi P, Malcom GT, Smialek J, Virmani R: Arterial remodeling in the left coronary system. J Am Coll Cardiol 1999; 34: 760–767 [DOI] [PubMed] [Google Scholar]
  • 15. Mahoney LT, Burns TL, Stanford W, Thompson BH, Witt JD, Rost CA, Lauer RM: Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study. J Am Coll Cardiol 1996; 27: 277–284 [DOI] [PubMed] [Google Scholar]
  • 16. Geng YJ, Libby P: Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin‐1 beta‐converting enzyme. Am J Pathol 1995; 147 (2): 229–234 [PMC free article] [PubMed] [Google Scholar]
  • 17. Cockerill GW, Rye K‐A, Gamble JR, Vadas MA, Barter PJ: High‐density lipoproteins inhibit cytokine‐induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987–1994 [DOI] [PubMed] [Google Scholar]
  • 18. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809 [DOI] [PubMed] [Google Scholar]
  • 19. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM: Restenosis after experimental angioplasty: Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995; 76: 996–1002 [DOI] [PubMed] [Google Scholar]
  • 20. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ: Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium‐mediated intracellular signaling in human osteoclast‐like cells. J Cell Biol 1994; 127: 1149–1158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994; 145: 1450–1462 [PMC free article] [PubMed] [Google Scholar]
  • 22. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE: Effects of high‐density lipoprotein on acetylcholine‐induced coronary vasoreactivity. Am J Cardiol 1991; 68: 1425–1430 [DOI] [PubMed] [Google Scholar]
  • 23. Matsuda Y, Hirata K, Inoue N, Suematsu M, Kawashima S, Akita H, Yokoyama M: High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium‐dependent arterial relaxation. Circ Res 1993; 72: 1103–1109 [DOI] [PubMed] [Google Scholar]
  • 24. Tauber J, Cheng J, Gospodarowicz D: Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest 1980; 66: 696–708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C: Serum prostacyclin stabilizing factor is identical to apolipoprotein A‐I (Apo A‐I). A novel function of Apo A‐I. J Clin Invest 1988; 82: 803–807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Chobanian AV, Haudenschild CC, Nickerson C, Drago R: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1992; 15: 327–331 [DOI] [PubMed] [Google Scholar]
  • 27. Clozel M, Kühn H, Hefti F, Baumgartner HR: Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Hypertension 1991; 18: 132–141 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES